What Does Sarepta Therapeutics' Director Share Sale Signal to Investors

Related Articles

What Does Director Mitchell Tyson's Substantial Share Sale Mean for Photronics Investors

6 months ago

What Does Director Edman's Recent Sale Mean for TTMI Investors

6 months ago

What Does a CAO's Share Sale and Resignation Signal for Enhabit (EHAB) Investors

6 months ago

What Does Senator Peters' Corteva Sale Signal to Investors

4 months ago

Category

You may also like

Stock News•3 weeks ago

LivaNova Director Sells 1,650 Shares for $131,500

A LivaNova director sold 1,650 shares for ~$131,500, equal to 17% of their direct stake before the filing. The transaction reduces the director's direct holdings, with no stated catalyst.

LIVN

Share

Stock News•1 months ago

Sarepta Therapeutics Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sarepta Therapeutics, Inc. - SRPT

Kahn Swick & Foti launched an investigation into Sarepta Therapeutics' officers and directors, following the company's Elevidys Duchenne muscular dystrophy therapy. The probe could pressure SRPT share...

SRPT

Share

Stock News•2 months ago

What This PTC Therapeutics Insider Sale Means as Product Revenue Hit $226 Million

PTC Therapeutics product revenue reached $226M, while an insider sold shares at ~$90.25, generating $222K from option exercises. The sale represented 4% of the insider's direct holdings.

PTC

Share